Cortice Biosciences Announces Presentation of Results from Placebo-Controlled Phase 1 Clinical Trials Evaluating TPI 287 for Treatment of Alzheimer’s Disease and Related Tauopathies

Cortice Biosciences Announces Presentation of Results from Placebo-Controlled Phase 1 Clinical Trials Evaluating TPI 287 for Treatment of Alzheimer’s Disease and Related Tauopathies

Possible evidence of clinical activity in Alzheimer’s disease patients treated with TPI 287 Drug administration was generally well-tolerated Results support further exploration of TPI 287 for…

Bookmark (0)

No account yet? Register

Cannabidiol Significantly Reduces Seizures in Patients with Severe Form of Epilepsy

Cannabidiol Significantly Reduces Seizures in Patients with Severe Form of Epilepsy

Summary: Researchers provide further evidence that the cannabis compound, CBD, is effective at reducing seizures in people with epilepsy. The new study reveals CBD significantly reduced…

Bookmark (0)

No account yet? Register

End of content

End of content